FDA provides fast track designation to nipocalimab for systemic lupus erythematosus

RSS feed for the Science and Medicine forum
Post Reply
User avatar
RSS Post Bot
Reactions:
Posts: 23012
Joined: Fri Aug 05, 2022 8:49 pm

#1

Post by RSS Post Bot »

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).

Source: https://medicalxpress.com/news/2026-03- ... lupus.html
Post Reply